Many of the plant-derived compounds used in chemotherapies are currently produced by semisynthesis, which results in limited supplies at exorbitant market prices. However, the synthetic biology era, which began ca 15 years ago, has progressively yielded encouraging advances by using engineered microbes for the practical production of cheaper plant anticancer drugs.
Keywords: metabolic engineering; microorganisms; plant; specialized metabolites; synthetic biology.
Copyright © 2020 Elsevier Inc. All rights reserved.